UK Decision Soon On Pfizer/Flynn’s “Excessive” Phenytoin Price Rises

As the Mylan EpiPen controversy in the US draws yet more attention to price increases on certain pharmaceutical products, an imminent decision by the UK competition authorities should help to clarify what should constitute “excessive” and “unfair” pricing.